Several new targets of antitumor agents

Area of Science:

• Oncology
• Molecular Biology
• Gene Therapy

Background:

• Alpha-fetoprotein (AFP) promotes hepatoma growth, making it a target for anti-cancer therapies.
• Current cancer treatment research explores inhibiting oncogene expression as a therapeutic strategy.
• Tumor cell differentiation and apoptosis induction are emerging approaches in cancer drug development.

Purpose of the Study:

• To explore novel therapeutic targets and strategies for treating hepatoma.
• To investigate the potential of inhibiting oncogene expression for cancer treatment.
• To evaluate the efficacy of inducing tumor cell differentiation and apoptosis in cancer therapy.

Main Methods:

• Developing gene therapy agents to inhibit oncogene expression.
• Investigating drugs that induce tumor cell differentiation.
• Utilizing suicide genes for targeted cancer therapy.

Main Results:

• Alpha-fetoprotein (AFP) identified as a key factor in hepatoma progression.
• Inhibiting oncogene expression shows promise as a novel anti-cancer approach.
• Induction of tumor cell differentiation and apoptosis are effective mechanisms for anti-tumor drugs.
• Suicide gene therapy enhances conventional chemotherapy with broad application potential.

Conclusions:

• Targeting AFP and oncogene expression represents a new frontier in anti-hepatoma drug development.
• Gene therapy, including suicide gene applications, offers improved and targeted cancer treatment options.
• Inducing tumor cell differentiation and apoptosis are viable strategies for novel anti-cancer drug design.